For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Product sourcing reference

Cognitive Compound References

Evaluate evidence, jurisdiction and formulation for cognitive-related compounds without treating a nootropic label as medical authorization.

7 compounds in this category

Reference variants and pricing

Add variants to your order request. Prices are reference estimates pending eligibility and availability review.

Dihexa

Cognitive from $31.63/unit
  • 10mgVial · confirm physical formCAS 1401708-83-5
    $31.63/vial$25.30/vial at 1,000+ vials of this item
    vials, packs of 10

DSIP

Cognitive from $25.88/unit
  • 10mgVial · confirm physical formCAS 62568-57-4
    $25.88/vial$20.70/vial at 1,000+ vials of this item
    vials, packs of 10
  • 15mgSpray bottleCAS 62568-57-4
    $30.00/bottle$20.00/bottle at 50+ bottles of this item
    bottles

Pinealon

Cognitive from $14.38/unit
  • 10mgVial · confirm physical formCAS 175175-23-2
    $14.38/vial$11.50/vial at 1,000+ vials of this item
    vials, packs of 10

Selank

Cognitive from $16.45/unit
  • 10mgVial · confirm physical formCAS 129954-34-3
    $16.45/vial$13.16/vial at 1,000+ vials of this item
    vials, packs of 10
  • 20mgSpray bottleCAS 129954-34-3
    $30.00/bottle$20.00/bottle at 50+ bottles of this item
    bottles

Semax

Cognitive from $12.65/unit
  • 10mgVial · confirm physical formCAS 80714-61-0
    $12.65/vial$10.12/vial at 1,000+ vials of this item
    vials, packs of 10
  • 25mgSpray bottleCAS 80714-61-0
    $30.00/bottle$20.00/bottle at 50+ bottles of this item
    bottles

Semax / Selank Blend

Cognitive from $45.00/unit
  • 20mg (10/10)Vial · confirm physical formCAS Multi-component
    Quote requiredReference listed as discontinued. Historical reference $24.44/vial; not an offer.
    Ask for a quote
  • 10mg/10mgSpray bottleCAS 80714-61-0 / 129954-34-3
    $45.00/bottle$30.00/bottle at 50+ bottles of this item
    bottles

Cerebrolysin

CognitiveInformational only

Not in the current reference price list. Read the sourcing notes or contact us.

Evidence must match the exact substance and route

Selank and Semax discussions may reference different routes, analogs or overseas products. A finding about one preparation cannot automatically support another.

Mixtures require different characterization

Cerebrolysin is not a single sequence-defined peptide. Comparing it with Selank or Semax using one generic purity percentage obscures important identity and composition questions.

Compare the studied substance and delivery format

A nootropic description does not identify a product. Semax and Selank require separate specifications; their blend is another formulation. A Cerebrolysin mixture cannot be evaluated using a single-peptide identity standard.

Make the comparison specific

Record the exact analogue, salt and route addressed by each document. Do not transfer evidence between nasal and vial preparations or treat overseas use as U.S. authorization. FDA identifies safety information gaps for multiple compounds in this group.

Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Non-clinical protocol review checklist. These references support a review, not a treatment recommendation or supply authorization.

Call Apply for Wholesale